Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Significance of PEAK1 Expression and BRAF V600E Mutation in Papillary Thyroid Cancer.

British journal of biomedical science - 1 Jan 2022

Li P, Zhao H, Liu X, Huang Y, Chen D

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to Protein-Tyrosine Kinases
Share to Proto-Oncogene Proteins B-raf
Share to Thyroid Cancer, Papillary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 35996515
DOI: 10.3389/bjbs.2021.10268
PMCID: PMC8915583

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Significance of PEAK1 Expression and BRAF V600E Mutation in Papillary Thyroid Cancer.PMID 35996515Read ↗

Papillary Thyroid Carcinoma: Correlation Between Molecular and Clinical Features.Semantic proximity Read ↗

Integrated genomic characterization of papillary thyroid carcinoma.Semantic proximity Read ↗

Significance of the BRAF mRNA Expression Level in Papillary Thyroid Carcinoma: An Analysis of The Cancer Genome Atlas Data.Semantic proximity Read ↗

Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions.Semantic proximity Read ↗

BRAF-activated WT1 contributes to cancer growth and regulates autophagy and apoptosis in papillary thyroid carcinoma.Semantic proximity Read ↗

Correlation of immunohistochemical markers and BRAF mutation status with histological variants of papillary thyroid carcinoma in the Korean population.Semantic proximity Read ↗

Targeting cyclin D1 as a therapeutic approach for papillary thyroid carcinomaSemantic proximity Read ↗

MUC1 expression in papillary thyroid carcinoma is associated with BRAF mutation and lymph node metastasis; the latter is the most important risk factor of relapse.Semantic proximity Read ↗

Significance of BRAF mutations in papillary thyroid carcinoma: prognostic and therapeutic implications.Semantic proximity Read ↗

Gene expression profile of human thyroid cancer in relation to its mutational status.Semantic proximity Read ↗

Genome-Wide Profiling of Papillary Thyroid Cancer Identifies MUC1 as an Independent Prognostic MarkerSemantic proximity Read ↗

Can mutation abundance assess the biological behavior of BRAFV600E-positive papillary thyroid carcinoma?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.